
Benjamin J. Packard
Examiner (ID: 7369, Phone: (571)270-3440 , Office: P/1612 )
| Most Active Art Unit | 1612 |
| Art Unit(s) | 1609, 1612, 4173 |
| Total Applications | 1700 |
| Issued Applications | 945 |
| Pending Applications | 209 |
| Abandoned Applications | 578 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20656581
[patent_doc_number] => 20260108615
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-04-23
[patent_title] => SELF-ASSEMBLED MUCOADHESIVE BIOPOLYMER PARTICLE RELEASE SYSTEM AND PREPARATION METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/697611
[patent_app_country] => US
[patent_app_date] => 2022-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5829
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18697611
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/697611 | SELF-ASSEMBLED MUCOADHESIVE BIOPOLYMER PARTICLE RELEASE SYSTEM AND PREPARATION METHOD THEREOF | Sep 28, 2022 | Pending |
Array
(
[id] => 18836745
[patent_doc_number] => 11844802
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-19
[patent_title] => Compounds and compositions for ossification and methods related thereto
[patent_app_type] => utility
[patent_app_number] => 17/936184
[patent_app_country] => US
[patent_app_date] => 2022-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 27
[patent_no_of_words] => 13557
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17936184
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/936184 | Compounds and compositions for ossification and methods related thereto | Sep 27, 2022 | Issued |
Array
(
[id] => 18460358
[patent_doc_number] => 11684636
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-06-27
[patent_title] => Stable, highly pure l-cysteine compositions for injection and methods of use
[patent_app_type] => utility
[patent_app_number] => 17/950979
[patent_app_country] => US
[patent_app_date] => 2022-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 28643
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17950979
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/950979 | Stable, highly pure l-cysteine compositions for injection and methods of use | Sep 21, 2022 | Issued |
Array
(
[id] => 18427624
[patent_doc_number] => 11672824
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-06-13
[patent_title] => Stable, highly pure L-cysteine compositions for injection and methods of use
[patent_app_type] => utility
[patent_app_number] => 17/950964
[patent_app_country] => US
[patent_app_date] => 2022-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 28639
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17950964
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/950964 | Stable, highly pure L-cysteine compositions for injection and methods of use | Sep 21, 2022 | Issued |
Array
(
[id] => 18209252
[patent_doc_number] => 20230055512
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => METHOD OF TREATMENT OF TOPICAL DERMATOLOGIC ACNE USING A CREAM COMPOSITION AND METHOD OF MANUFACTURE
[patent_app_type] => utility
[patent_app_number] => 17/901688
[patent_app_country] => US
[patent_app_date] => 2022-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7950
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17901688
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/901688 | Method of treatment of topical dermatologic acne using a cream composition and method of manufacture | Aug 31, 2022 | Issued |
Array
(
[id] => 18434176
[patent_doc_number] => 20230181470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING DISORDERS AMELIORATED BY MUSCARINIC RECEPTOR ACTIVATION
[patent_app_type] => utility
[patent_app_number] => 17/822872
[patent_app_country] => US
[patent_app_date] => 2022-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27086
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17822872
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/822872 | Compositions and methods for treating disorders ameliorated by muscarinic receptor activation | Aug 28, 2022 | Issued |
Array
(
[id] => 19798852
[patent_doc_number] => 20250064777
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-27
[patent_title] => PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER COMPRISING BRUCEANTIN AND NANOPARTICLES
[patent_app_type] => utility
[patent_app_number] => 18/700767
[patent_app_country] => US
[patent_app_date] => 2022-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3487
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18700767
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/700767 | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER COMPRISING BRUCEANTIN AND NANOPARTICLES | Aug 25, 2022 | Pending |
Array
(
[id] => 18279307
[patent_doc_number] => 20230094779
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => DRUG DELIVERY DEVICES FOR DELIVERY OF OCULAR THERAPEUTICS AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/887261
[patent_app_country] => US
[patent_app_date] => 2022-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22579
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17887261
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/887261 | DRUG DELIVERY DEVICES FOR DELIVERY OF OCULAR THERAPEUTICS AGENTS | Aug 11, 2022 | Abandoned |
Array
(
[id] => 18056257
[patent_doc_number] => 20220387343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => Transdermal Drug Delivery System
[patent_app_type] => utility
[patent_app_number] => 17/884727
[patent_app_country] => US
[patent_app_date] => 2022-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7864
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17884727
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/884727 | Transdermal drug delivery system | Aug 9, 2022 | Issued |
Array
(
[id] => 18673154
[patent_doc_number] => 20230310644
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => IONIZABLE LIPID COMPOUNDS, LIPID NANOPARTICLES COMPRISING SAME AND THERAPEUTIC USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/816427
[patent_app_country] => US
[patent_app_date] => 2022-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18293
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17816427
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/816427 | Ionizable lipid compounds, lipid nanoparticles comprising same and therapeutic uses thereof | Jul 31, 2022 | Issued |
Array
(
[id] => 18019135
[patent_doc_number] => 20220370634
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => POLYGLUTAMATED ANTIFOLATES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/875724
[patent_app_country] => US
[patent_app_date] => 2022-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29220
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -64
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17875724
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/875724 | Polyglutamated antifolates and uses thereof | Jul 27, 2022 | Issued |
Array
(
[id] => 19512182
[patent_doc_number] => 20240343868
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-17
[patent_title] => METHODS OF CROSSLINKING POLYMERS AND HYDROGEL MICROPARTICLES AND OF ENCAPSULATING BIOLOGICALLY ACTIVE COMPOUNDS, COMPOSITIONS MADE THEREFROM, AND DEVICES
[patent_app_type] => utility
[patent_app_number] => 18/580416
[patent_app_country] => US
[patent_app_date] => 2022-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17578
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18580416
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/580416 | METHODS OF CROSSLINKING POLYMERS AND HYDROGEL MICROPARTICLES AND OF ENCAPSULATING BIOLOGICALLY ACTIVE COMPOUNDS, COMPOSITIONS MADE THEREFROM, AND DEVICES | Jul 20, 2022 | Pending |
Array
(
[id] => 18353939
[patent_doc_number] => 11642323
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-09
[patent_title] => Method for modulating metabolism
[patent_app_type] => utility
[patent_app_number] => 17/813875
[patent_app_country] => US
[patent_app_date] => 2022-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 13
[patent_no_of_words] => 13909
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17813875
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/813875 | Method for modulating metabolism | Jul 19, 2022 | Issued |
Array
(
[id] => 18626494
[patent_doc_number] => 20230285279
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => BIODEGRADABLE ALPHA-2 AGONIST POLYMERIC IMPLANTS AND THERAPEUTIC USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/812893
[patent_app_country] => US
[patent_app_date] => 2022-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14843
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17812893
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/812893 | BIODEGRADABLE ALPHA-2 AGONIST POLYMERIC IMPLANTS AND THERAPEUTIC USES THEREOF | Jul 14, 2022 | Abandoned |
Array
(
[id] => 19477233
[patent_doc_number] => 20240325275
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-03
[patent_title] => ORAL CARE COMPOSITIONS WITH PHOSPHOPEPTIDES FOR USE AGAINST DENTAL HYPERSENSITIVITY AND/OR XEROSTOMIA
[patent_app_type] => utility
[patent_app_number] => 18/579107
[patent_app_country] => US
[patent_app_date] => 2022-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17747
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18579107
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/579107 | ORAL CARE COMPOSITIONS WITH PHOSPHOPEPTIDES FOR USE AGAINST DENTAL HYPERSENSITIVITY AND/OR XEROSTOMIA | Jul 10, 2022 | Pending |
Array
(
[id] => 17944233
[patent_doc_number] => 20220331250
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => HIGH-EFFICIENCY ENCAPSULATION OF HYDROPHILIC COMPOUNDS IN UNILAMELLAR LIPOSOMES
[patent_app_type] => utility
[patent_app_number] => 17/857302
[patent_app_country] => US
[patent_app_date] => 2022-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9792
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17857302
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/857302 | High-efficiency encapsulation of hydrophilic compounds in unilamellar liposomes | Jul 4, 2022 | Issued |
Array
(
[id] => 18799995
[patent_doc_number] => 11833139
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-05
[patent_title] => Rifabutin treatment methods, uses, and compositions
[patent_app_type] => utility
[patent_app_number] => 17/833326
[patent_app_country] => US
[patent_app_date] => 2022-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8759
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17833326
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/833326 | Rifabutin treatment methods, uses, and compositions | Jun 5, 2022 | Issued |
Array
(
[id] => 19387981
[patent_doc_number] => 20240277851
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-22
[patent_title] => siRNA DELIVERY VECTOR
[patent_app_type] => utility
[patent_app_number] => 18/562733
[patent_app_country] => US
[patent_app_date] => 2022-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10012
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18562733
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/562733 | siRNA DELIVERY VECTOR | Jun 2, 2022 | Pending |
Array
(
[id] => 18227188
[patent_doc_number] => 20230066182
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => RIFABUTIN TREATMENT METHODS, USES, AND COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/826817
[patent_app_country] => US
[patent_app_date] => 2022-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10215
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17826817
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/826817 | Rifabutin treatment methods, uses, and compositions | May 26, 2022 | Issued |
Array
(
[id] => 19570488
[patent_doc_number] => 20240374780
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-14
[patent_title] => ANTIMICROBIAL COMPONENT FOR A WOUND DRESSING
[patent_app_type] => utility
[patent_app_number] => 18/564143
[patent_app_country] => US
[patent_app_date] => 2022-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8843
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18564143
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/564143 | ANTIMICROBIAL COMPONENT FOR A WOUND DRESSING | May 26, 2022 | Pending |